Evidence
Adv Clin Chem. 2023;114:83-108. doi: 10.1016/bs.acc.2023.02.001. Epub 2023 May 5.
ABSTRACT
Chronic and heavy alcohol consumption is commonly observed in alcohol use disorder (AUD). AUD often leads to alcohol-associated organ injury, including alcohol-associated liver disease (ALD). Approximately 10-20% of patients with AUD progress to ALD. Progression of ALD from the development phase to more advanced states involve the interplay of several pathways, including nutritional alterations. Multiple pathologic processes have been identified in the progression and severity of ALD. However, there are major gaps in the characterization and understanding of the clinical presentation of early-stage ALD as assessed by clinical markers and laboratory measures. Several Institutions and Universities, including the University of Louisville, in collaboration with the National Institutes of Health, have published a series of manuscripts describing early-stage ALD over the past decade. Here, we comprehensively describe early-stage ALD using the liver injury and drinking history markers, and the laboratory biomarkers (with a focus on nutrition status) that are uniquely involved in the development and progression of early-stage ALD.
PMID:37268335 | DOI:10.1016/bs.acc.2023.02.001
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Real-Time Evidence Search [Psychiatry]
Drinking and laboratory biomarkers, and nutritional status characterize the clinical presentation of early-stage alcohol-associated liver disease
🌐 90 Days
VR Related Evidence Matrix
- Alcohol-Related liver disease: A global perspective
- Molecular insights on intracellular Wnt/β-catenin signaling in alcoholic liver disease
- Molecular insights on intracellular Wnt/β-catenin signaling in alcoholic liver disease
- 1H NMR Serum Metabolomic Change of Trimethylamine N-oxide (TMAO) Is Associated with Alcoholic Liver Disease Progression
- Safety and compliance of long-term low-dose ondansetron in alcohol use disorder treatment
- Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease
- Increased Intestinal Permeability and Decreased Resiliency of the Intestinal Barrier in Alcoholic Liver Disease
- Increased Intestinal Permeability and Decreased Resiliency of the Intestinal Barrier in Alcoholic Liver Disease
- Critical misconceptions and knowledge gaps regarding alcohol cessation and risk of relapse in alcohol-related liver disease patients: A qualitative mental models study
- Infections increase the risk of decompensation and death in patients with early alcohol-related liver disease
- Hepatic extracellular ATP/adenosine dynamics in zebrafish models of alcoholic and metabolic steatotic liver disease
- ERRgamma-inducible FGF23 promotes alcoholic liver injury through enhancing CYP2E1 mediated hepatic oxidative stress
- Review article: Current indications and selection criteria for early liver transplantation in severe alcohol-associated hepatitis
- Aldo-keto reductase family 1 member A1 (AKR1A1) exerts a protective function in alcohol-associated liver disease by reducing 4-HNE accumulation and p53 activation
- Higher-Than-Expected Burden of Alcohol-Related Liver Diseases During COVID-19 Pandemic in the USA, with a Tapering Trend
- Epidemiology of alcohol use and alcohol use disorders among people living with HIV on antiretroviral therapy in Northwest Tanzania: implications for ART adherence and case management
- Interaction between fatty acid oxidation and ethanol metabolism in liver
- Ethanol extracts of Isochrysis zhanjiangensis alleviate acute alcoholic liver injury and modulate intestinal bacteria dysbiosis in mice
- Exploring the Potential Role of Massa Medicata Fermentata in Alcoholic Liver Injury Disease Based on Network Pharmacology and Animal Experiments
- Subjective stress and any drinking during alcohol treatment: Disentangling within and between person autoregressive effects
- Alcohol Use Disorder Treatment: Problems and Solutions
- Effects of prazosin treatment on liver enzymes are moderated by alcohol withdrawal symptoms in individuals with alcohol use disorder
- Glucosamine attenuates alcohol-induced acute liver injury via inhibiting oxidative stress and inflammation
- Cyanidin-3-O-Glucoside Alleviates Alcoholic Liver Injury via Modulating Gut Microbiota and Metabolites in Mice
- Nociplastic Pain and Pain-Motivated Drinking in Alcohol Use Disorder
- Exploring patterns of alcohol use and alcohol use disorder among Asian Americans with a finer lens
- Patterns of drinking behavior around a treatment episode for alcohol use disorder: Predictions from pre-treatment measures
- Serial mediating effects of childhood trauma and conduct behaviors on the impact of family history among patients with alcohol use disorder
- Medication-based treatment among rural, primary care patients diagnosed with opioid use disorder and alcohol use disorder
- Neurogenetic and multi-omic sources of overlap among sensation seeking, alcohol consumption, and alcohol use disorder
- Gender-Specific Bile Acid Profiles in Non-Alcoholic Fatty Liver Disease
- Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
- Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
- Alcohol use disorders in patients with bipolar disorder: a systematic review and meta-analysis
- Alcohol use disorders in patients with bipolar disorder: a systematic review and meta-analysis
- COMPARISON OF GUT MICROBIOTA IN ALCOHOLIC AND METABOLIC-DYSFUNCION ASSOCIATED STEATOTIC LIVER DISEASE IN ANIMAL MODELS
- AUD in perspective
- Bariatric surgery patients in AUD treatment in Norway-an exploratory cross-sectional study
- Bariatric surgery patients in AUD treatment in Norway-an exploratory cross-sectional study
- Occult liver disease: a multinational perspective
- Non-alcoholic beverage consumption among US adults who consume alcohol
- Poria cocos polysaccharides improve alcoholic liver disease by interfering with ferroptosis through NRF2 regulation
- Amylin in Alcohol Addiction: A Potential New Treatment Target or an Adjuvant to Other Treatments?
- Antioxidation and Hepatoprotection of Selenium Mycelium Polysaccharides Against Alcoholic Liver Diseases from the Cultivated Morel Mushroom Morchella esculenta (Ascomycota)
- Symbiotic combination of Akkermansia muciniphila and inosine alleviates alcohol-induced liver injury by modulating gut dysbiosis and immune responses
- Regulation of intestinal microflora and metabolites of Penthorum chinense Pursh on alcoholic liver disease
- The Impact of Probiotic Bifidobacterium on Liver Diseases and the Microbiota
- Changing trends in the etiology of liver transplantation in Turkiye: A multicenter study
- Mental Imagery to Reduce Alcohol-related harm in patients with alcohol use disorder and alcohol-related liver damaGE: the MIRAGE randomised pilot trial results
- Exploring the role of fear of missing out in coping and risk-taking among alcohol use disorder and general young adult populations
- Hepatoprotective effects of peach gum polysaccharides against alcoholic liver injury: moderation of oxidative stress and promotion of lipid metabolism
- Exploring Attentional Bias toward Alcohol Content: Insights from Eye-Movement Activity
- Prevalence of at-risk MASH, MetALD and alcohol-associated steatotic liver disease in the general population
- Early life stress and body-mass-index modulate brain connectivity in alcohol use disorder
- Microglia activity in the human basal ganglia is altered in alcohol use disorder and reversed with remission from alcohol
- Microglia activity in the human basal ganglia is altered in alcohol use disorder and reversed with remission from alcohol
- ENPP2/Autotaxin: The potential drug target for alcoholic liver disease identified through Mendelian randomization analysis
- Emerging Concepts in Alcohol, Infection & Immunity: A summary of the 2023 Alcohol and Immunology Research Interest Group (AIRIG) meeting
- Associations of severe liver diseases with cataract using data from UK Biobank: a prospective cohort study
- Increased Incidence of Depression and Chronic Pain in Traumatic Spinal Cord Injury Patients With Pre-Injury Alcohol Use Disorder: Longitudinal Analysis of Insurance Claim Database
- Alcoholic pellagrous encephalopathy: a case report on atypical presentation and diagnostic dilemma in alcohol-related disorders
- Characterizing the clinical subgroups of individuals who present to the emergency department for alcohol-related harms in Ontario, Canada: A latent class analysis
- Biological aging markers in blood and brain tissue indicate age acceleration in alcohol use disorder
- GABAergic mechanisms in alcohol dependence
Evidence Blueprint
Drinking and laboratory biomarkers, and nutritional status characterize the clinical presentation of early-stage alcohol-associated liver disease
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
Save Evidence Blueprint
Save as PDF
Drinking and laboratory biomarkers, and nutritional status characterize the clinical presentation of early-stage alcohol-associated liver disease
🌐 365 Days
VR Related Evidence Matrix
- Integrated Multidisciplinary Management of Alcohol-associated Liver Disease
- Management of alcohol use disorder in patients with chronic liver disease
- Alcohol-Related liver disease: A global perspective
- Integrated care models for co-occurring alcohol use disorders and alcohol-associated liver disease in rural communities: Telehealth considerations and opportunities
- Improving alcohol treatment engagement using integrated behavioral interventions in alcohol-associated liver disease: A randomized pilot trial
- Molecular insights on intracellular Wnt/β-catenin signaling in alcoholic liver disease
- Molecular insights on intracellular Wnt/β-catenin signaling in alcoholic liver disease
- Human Precision-Cut Liver Slices: A Potential Platform to Study Alcohol-Related Liver Disease
- 1H NMR Serum Metabolomic Change of Trimethylamine N-oxide (TMAO) Is Associated with Alcoholic Liver Disease Progression
- Biomarkers for monitoring alcohol sobriety after liver transplantation for alcoholic liver disease
- Safety and compliance of long-term low-dose ondansetron in alcohol use disorder treatment
- Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease
- Therapeutic targets in alcohol-associated liver disease: progress and challenges
- Increased Intestinal Permeability and Decreased Resiliency of the Intestinal Barrier in Alcoholic Liver Disease
- Increased Intestinal Permeability and Decreased Resiliency of the Intestinal Barrier in Alcoholic Liver Disease
- Blood Concentrations of Lead, Cadmium, and Mercury Are Associated With Alcohol-Related Liver Disease
- Prognostic Factors in Alcohol-associated Liver Disease Patients Presenting With First Evidence of Ascites
- The Monoacylglycerol Lipase Inhibitor ABX-1431 Does Not Improve Alcoholic Liver Disease
- Critical misconceptions and knowledge gaps regarding alcohol cessation and risk of relapse in alcohol-related liver disease patients: A qualitative mental models study
- Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes
- Recent insight into the role of macrophage in alcohol-associated liver disease: a mini-review
- Targeting hepatic serine-arginine protein kinase 2 ameliorates alcohol-associated liver disease by alternative splicing control of lipogenesis
- Hepatic progesterone receptor membrane component 1 attenuates ethanol-induced liver injury by reducing acetaldehyde production and oxidative stress
- Infections increase the risk of decompensation and death in patients with early alcohol-related liver disease
- Progress in the mechanism of autophagy and traditional Chinese medicine herb involved in alcohol-related liver disease
- Recent Advances in Mesenchymal Stem/Stromal Cell-Based Therapy for Alcohol-Associated Liver Disease and Non-alcoholic Fatty Liver Disease
- ZONAL EXPRESSION OF STARD1 AND OXIDATIVE STRESS IN ALCOHOLIC-RELATED LIVER DISEASE
- Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease
- Astaxanthin Protects against Alcoholic Liver Injury via Regulating Mitochondrial Redox Balance and Calcium Homeostasis
- Hepatic extracellular ATP/adenosine dynamics in zebrafish models of alcoholic and metabolic steatotic liver disease
- Exploring the microscopic changes of lipid droplets and mitochondria in alcoholic liver disease via fluorescent probes with high polarity specificity
- Insights of mitochondrial involvement in alcoholic fatty liver disease
- Alcohol and the mechanisms of liver disease
- Between-hospital care referrals for severe alcohol-related liver disease during the COVID-19 pandemic, 2020 to 2022
- Pyroptotic MAITs link microbial translocation with severity of alcohol-associated liver disease
- Alcohol use and hepatocellular carcinoma risk in patients with alcohol-related cirrhosis
- Challenges and Solutions for Monitoring Alcohol Use in Patients with Alcohol Related Liver Disease: Pilot Study of a Wearable Alcohol Biosensor
- Kaempferol ameliorated alcoholic liver disease through inhibiting hepatic bile acid synthesis by targeting intestinal FXR-FGF15 signaling
- Ceramide synthase 6 (CerS6) is upregulated in alcohol-associated liver disease and exhibits sex-based differences in the regulation of energy homeostasis and lipid droplet accumulation
- ERRgamma-inducible FGF23 promotes alcoholic liver injury through enhancing CYP2E1 mediated hepatic oxidative stress
- MELD-Na score may underestimate disease severity and risk of death in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
- Endoplasmic reticulum stress in the pathogenesis of alcoholic liver disease
- Protection of Inonotus hispidus (Bull.) P. Karst. against Chronic Alcohol-Induced Liver Injury in Mice via Its Relieving Inflammation Response
- Antioxidants ameliorate oxidative stress in alcoholic liver injury by modulating lipid metabolism and phospholipid homeostasis
- Ambiguous Pathogenic Roles of Macrophages in Alcohol-Associated Liver Diseases
- Non-invasive markers of inflammation in alcohol-associated liver disease: A scoping review
- NLRP3: a new therapeutic target in alcoholic liver disease
- Review article: Current indications and selection criteria for early liver transplantation in severe alcohol-associated hepatitis
- The Influence of Insulin Resistance on Outcomes in Hospitalizations for Alcohol-Related Liver Disease: A Nationwide Study
- Aldo-keto reductase family 1 member A1 (AKR1A1) exerts a protective function in alcohol-associated liver disease by reducing 4-HNE accumulation and p53 activation
- Outcomes of re-referrals of patients with alcohol-related liver disease who were previously declined for liver transplantation
- The role of neutrophils in alcohol-related hepatitis
- Mifepristone as a pharmacological intervention for stress-induced alcohol craving: A human laboratory study
- Lactobacillus plantarum ST-III culture supernatant protects against acute alcohol-induced liver and intestinal injury
- Ferroptosis contributes to ethanol-induced hepatic cell death via labile iron accumulation and GPx4 inactivation
- Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases
- Hydrogen gas ameliorates acute alcoholic liver injury via anti-inflammatory and antioxidant effects and regulation of intestinal microbiota
- Alcohol Consumption Post-Liver Transplantation: A Cross-Sectional Study
- Alcohol consumption and the risk of liver disease: a nationwide, population-based study
- Porphyromonas gingivalis exacerbates alcoholic liver disease by altering gut microbiota composition and host immune response in mice
- Higher-Than-Expected Burden of Alcohol-Related Liver Diseases During COVID-19 Pandemic in the USA, with a Tapering Trend
- Fenofibrate inhibits MOXD1 and PDZK1IP1 expression and improves lipid deposition and inflammation in mice with alcoholic fatty liver
- Genetic Underpinnings of the Transition From Alcohol Consumption to Alcohol Use Disorder: Shared and Unique Genetic Architectures in a Cross-Ancestry Sample
- Lipid and renal profile in assessing the severity of alcoholic liver disease